The thyroid gland was one of the first organs imaged in nuclear medicine, beginning in the
1940s. Thyroid scintigraphy is based on a specific phase or prelude to thyroid hormone …

Radioactive iodine (RAI) is used in treatment of patients with differentiated papillary and
follicular thyroid cancer. It is typically used after thyroidectomy, both as a means of imaging …

Introduction We assessed the suitability of the radiolanthanide 155 Tb (t 1/2= 5.32 days, E γ=
87 keV (32%), 105 keV (25%)) in combination with variable tumor targeted biomolecules …

Detection of residual tissue after thyroidectomy for papillary or follicular thyroid carcinoma
may be performed using diagnostic imaging with either 123I or 131I. The former is often …

Purpose In differentiated thyroid carcinoma (DTC), 131 I-SPECT/CT is more accurate in
identifying radioiodine-positive lymph node metastases (LNM) than planar whole-body …

Objective: Dosimetry studies have shown that activities of 131 I as small as 10-20 MBq may
cause a stunning effect. A result of this stunning effect may be a lower success rate of the …

Objective We assessed the performance of 37 MBq I-123 as a diagnostic imaging agent in
patients with differentiated thyroid cancer using comparisons with their corresponding high …

Thyroid cancer accounts for only 0.4% of all cancer deaths, with an incidence of 11 cases
and about 0.5-0.6 deaths per 100,000 population in the United States each year, according …

Objective We assessed the lesion detectability of low-dose diagnostic 123 I-
metaiodobenzylguanidine (MIBG) whole-body scans obtained at 6 and 24 h compared with …

Objectives: The rate and impact of thyroglossal duct remnant (TGDR) visualization in
patients with hypothyroidism after total thyroidectomy for differentiated thyroid carcinoma …